Tyrvaya® (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease.
Sponsored Content: Overview of dry eye disease pathophysiology and proper administration technique for the Tryvaya nasal spray. Tyrvaya is a registered trademark of Oyster Point Pharma, Inc., a Viatris Company.
Indication
Tyrvaya® (varenicline solution) nasal spray is indicated for the treatment of the signs and symptoms of dry eye disease.
Important Safety Information
The most common adverse reaction reported is 82% of patients was sneezing. Events that were reported in 5-16% of patients were cough, throat irritation, and instillation-site (nose) irritation.
